This was compared to a standard, equicaloric load of MDX
Retatrutide is a triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously, whereas semaglutide acts on GLP-1 receptors alone and tirzepatide targets both GIP and GLP-1 receptors
No in-person visits are required at any stage, which suits adults in areas with limited specialist access or those managing demanding schedules
Redness, swelling, itch, and local pain at injection sites are common
Kidney and Renal Complications: Ozempic has been linked to acute kidney injuries, particularly in those with pre-existing kidney issues, potentially exacerbated by dehydration from gastrointestinal side effects
Since compounded medication is not produced by the manufacturer in dosages that have been clinically tested, it's not FDA-approved